5BK5

Crystal structure of the anti-circumsporozoite protein 663 germline antibody

5BK5 の概要

• エントリーDOI: 10.2210/pdb5bk5/pdb
• 関連するPDBエントリー: 5BK0 5BK3 6AZM
• 分子名称: 663 germline antibody, heavy chain, 663 germline antibody, light chain, GLYCEROL (3 entities in total)
• 機能のキーワード: malaria, circumsporozoite protein, fab, immune system
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 191637.88

構造登録者

Scally, S.W.,Bosch, A.,Triller, G.,Wardemann, H.,Julien, J.P. (登録日: 2017-09-12, 公開日: 2017-12-13, 最終更新日: 2024-10-23)

主引用文献

Triller, G.,Scally, S.W.,Costa, G.,Pissarev, M.,Kreschel, C.,Bosch, A.,Marois, E.,Sack, B.K.,Murugan, R.,Salman, A.M.,Janse, C.J.,Khan, S.M.,Kappe, S.H.I.,Adegnika, A.A.,Mordmuller, B.,Levashina, E.A.,Julien, J.P.,Wardemann, H.
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.
Immunity, 47:1197-1209.e10, 2017

PubMed Abstract: Antibodies against the NANP repeat of circumsporozoite protein (CSP), the major surface antigen of Plasmodium falciparum (Pf) sporozoites, can protect from malaria in animal models but protective humoral immunity is difficult to induce in humans. Here we cloned and characterized rare affinity-matured human NANP-reactive memory B cell antibodies elicited by natural Pf exposure that potently inhibited parasite transmission and development in vivo. We unveiled the molecular details of antibody binding to two distinct protective epitopes within the NANP repeat. NANP repeat recognition was largely mediated by germline encoded and immunoglobulin (Ig) heavy-chain complementarity determining region 3 (HCDR3) residues, whereas affinity maturation contributed predominantly to stabilizing the antigen-binding site conformation. Combined, our findings illustrate the power of exploring human anti-CSP antibody responses to develop tools for malaria control in the mammalian and the mosquito vector and provide a molecular basis for the structure-based design of next-generation CSP malaria vaccines.

PubMed: 29195810
DOI: 10.1016/j.immuni.2017.11.007

実験手法

X-RAY DIFFRACTION (3 Å)